Impaired sensitivity in non-responders to pegylated interferon plus ribavirin therapy assessed by 2′-5′-oligoadenylate synthetase activity

被引：0
|
作者：
Shindo, Michiko
Hamada, Kazushige
Morikawa, Teruhisa
Harano, Yuichi
Nakajima, Tomoaki
Okuno, Tadao
机构：
[1] Akashi Municipal Hosp, Akashi, Hyogo, Japan
[2] Kyoto Inst Technol, Kyoto 606, Japan
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
333
引用
收藏
页码：388A / 388A
页数：1
相关论文
共 50 条
  • [41] Controlled study of interferon α-2β (IFN) plus ribavirin (RIB) in patients with chronic hepatitis C (CHC) "non-responders" to IFN.
    Moreno-Otero, R
    HEPATOLOGY, 2002, 36 (04) : 595A - 595A
  • [42] The role of caspase activity in the viral response of pegylated interferon alfa-2B plus ribavirin therapy
    Oze, Tsugiko
    Hiramatsu, Naoki
    Kanto, Tatsuya
    Kurashige, Nao
    Yakushijin, Takayuki
    Uyama, Hirokazu
    Igura, Takumi
    Oshita, Masahide
    Katayama, Kazuhiro
    Yoshihara, Harumasa
    Imai, Yasuharu
    Kato, Michio
    Takehara, Tetsuo
    Kasahara, Akinori
    Tamura, Shinji
    Hayashi, Norio
    HEPATOLOGY, 2006, 44 (04) : 313A - 314A
  • [43] Efficacy of daily consensus interferon and ribavirin compared to PEG-interferon α-2b and ribavirin in non-responders with chronic Hepatitis C
    Dollinger, MM
    Dridi, Y
    Lesske, J
    Behl, S
    Fleig, WE
    HEPATOLOGY, 2005, 42 (04) : 691A - 692A
  • [44] Combination therapy with interferon-α 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection
    Kallinowski, B
    Liehr, H
    Moeller, B
    Stremmel, W
    Wechsler, JG
    Wiese, M
    Goeser, T
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (03): : 199 - +
  • [45] Retreatment with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in pegylated interferon α-2b (12KD)/ribavirin non-responders with cirrhosis/advanced fibrosis:: Repeat interim analysis
    Gitlin, N.
    Jensen, D.
    Di Bisceglie, A.
    Berg, T.
    Salmeron, J.
    Rizzetto, M.
    Yurdaydin, C.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S213 - S214
  • [46] Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.
    Carmen, SE
    HEPATOLOGY, 2002, 36 (04) : 588A - 588A
  • [47] Antiviral effect of ribavirin in non-responders to interferon alone assessed by kinetics of hepatitis C virus RNA and HCV core antigen
    Lunel, F
    Veillon, P
    Fouchard-Hubert, I
    Loustaud-Ratti, V
    Payan, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 152 - 152
  • [48] Interferon-α-2b+ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α-monotherapy
    Tromm, A
    Greving, I
    Griga, T
    Mankel, K
    Hüppe, D
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (02): : 159 - 164
  • [49] Prospective, randomized and controlled study of the efficacy of interferon alpha 2b plus ribavirin in chronic hepatitis C non-responders to prior interferon courses
    Moreno-Otero, R
    JOURNAL OF HEPATOLOGY, 2001, 34 : 166 - 167
  • [50] Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial
    Ishida, H
    Inoue, Y
    Wong, JB
    Okita, K
    HEPATOLOGY RESEARCH, 2004, 28 (03) : 125 - 136
12345